Update on HIV/AIDS in Thailand

Journal of the Medical Association of Thailand

Volumn 84, Issue SUPPL. 1, 2001, Pages

  Ruxrungtham, Kiat ^a   Phanuphak, Praphan ^b  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

Author keywords

AIDS; Antiretrovirals; HAART; HIV; Opportunistic; Subtype A E; Thailand; Vaccine

Indexed keywords

ABACAVIR; ALVAC; AMPHOTERICIN B; AMPRENAVIR; ANTIINFECTIVE AGENT; ANTIRETROVIRUS AGENT; AZITHROMYCIN; COTRIMOXAZOLE; DAPSONE; DELAVIRDINE; DIDANOSINE; EFAVIRENZ; FOLINIC ACID; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; INDINAVIR; ISONIAZID; LAMIVUDINE; LOPINAVIR; NELFINAVIR; NEVIRAPINE; PENTAMIDINE; PROTEINASE INHIBITOR; PYRIDOXINE; PYRIMETHAMINE; RITONAVIR; RNA DIRECTED DNA POLYMERASE INHIBITOR; SAQUINAVIR; STAVUDINE; UNCLASSIFIED DRUG; ZALCITABINE; ZIDOVUDINE;

CANDIDIASIS; CHEMOPROPHYLAXIS; CHRONIC DIARRHEA; CLINICAL FEATURE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; CRYPTOCOCCOSIS; DISEASE COURSE; EPIDEMIC; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MOLECULAR BIOLOGY; MYCOBACTERIUM INTRACELLULARE AVIUM; MYCOSIS; OPPORTUNISTIC INFECTION; PAPULAR SKIN DISEASE; PENICILLIUM MARNEFFEI; PNEUMOCYSTIS PNEUMONIA; PRACTICE GUIDELINE; REVIEW; THAILAND; TOXOPLASMOSIS; TUBERCULOSIS; VERTICAL TRANSMISSION; VIRUS TYPING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-HIV AGENTS; FEMALE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; THAILAND;

EID: 0034805024     PISSN: 01252208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (76)

1. Phanuphak P, Locharernkul C, Panmuong W, Wilde H. A report of three cases of AIDS in Thailand. Asian Pac J Allergy Immunol 1985; 3: 195-9.
2. Anonymous. End of 2000 HIV/AIDS Epidemiology Update. www.unaids.org/eptdemic_update/.
3. Weniger BG, Limpakarnjanarat K, Ungchusak K, et al. The epidemiology of HIV in Thailand. AIDS 1991;5:S71-S85.
4. Nelson KE. Overview of the HIV/AIDS epidemic in Thailand. Annu Conf Australas Soc HIV Med 1997; Nov 13-16; 9: 53 (abstract no. IS 22).
5. Anonymous. Results from national HIV serosurveillance, Thailand, 1989-1996. Bangkok, Ministry of Public Health (MOPH), 1996.
6. NESDB working group. Projection for HIV in Thailand 1987-2025. Research report, Human Resources Planning Division, National Economic and Social Development Board, Bangkok, Thailand. Nov 1994.
7. Brown T, Sittitrai W, Vanichseni S, Thisyakorn U. The recent epidemiology of HIV and AIDS in Thailand. AIDS 1994; 8 (Suppl 2): S131-41.
8. Surasiengsunk S, Kiranandana S, Wongboonsin K, et al. Demographic impact of the HIV epidemic in Thailand. AIDS 1998; 12: 775-84.
9. Ministry of Public Health, Thailand. HIV/AIDS, epidemiology reports as of October 2000. www. moph.go.th/ops/epi/aidshtm/indexaids.html.
10. Nelson KE, Celentano DD, Eiumtrakol S, et al. Changes in sexual behavior and a decline in HIV infection among young men in Thailand. N Engl J Med 1996; 335: 297-03.
11. Hanenberg RS, Rojanapithayakorn W, Kunasol P, Sokal DC. Impact of Thailand's HIV-control programme as indicated by the decline of sexually transmitted diseases. Lancet 1994; 344: 243-5.
12. Mason CJ, Kitsiripornchai S, Markowitz LE, et al. Nationwide surveillance of HIV-1 prevalence and subtype in young Thai men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 19: 165-73.
13. Celentano DD, Nelson KE, Lyles CM, et al. Decreasing incidence of HIV and sexually transmitted diseases in young Thai men: evidence for success of the HIV/AIDS control and prevention program. AIDS 1998; 12: F29-36.
14. Ou CY, Takebe Y, Weniger BG, et al. Independent introduction of two major HIV-1 genotypes into distinct high-risk populations in Thailand. Lancet 1993; 341: 1171-4.
15. Weniger BG. Takebe Y, Ou CY, Yamazaki S. The molecular epidemiology of HIV in Asia. AIDS 1994; 8: S13-28.
16. Taechowisan T, Sutthent R, Louisirirotchanakul S, et al. V3 peptide enzyme immunoassay for serotyping HIV-1 infected pregnant Thais. Asian Pacific J Allergy Immunol 1996; 14: 121-3.
17. Beyrer C, Artenstein A, Kunawararak P, et al. The molecular epidemiology of HIV-1 among male sex workers in northern Thailand. J Acquir Immun Def Syndr Hum Retrovirol 1997; 15: 304-7.
18. Ubolyam S, Ruxrungtham K, Sirivichayakul S, et al. Evidence of three HIV-1 subtypes in subgroups of individuals in Thailand [letter]. Lancet. 1994; 344: 485-6.
19. Soto-Ramirez LE, Renjifo B, McLane MF, et al. HIV-1 Langerhans' cell tropism associated with heterosexual transmission of HIV. Science 1996; 271: 1291-3.
20. Pope M, Frankel SS, Mascola JR, et al. Human immunodeficiency virus type 1 strains of subtypes B and E replicate in cutaneous dendritic cell-T-cell mixtures without displaying subtypespecific tropism. J Virol 1997; 71: 8001-7.
21. Wasi C, Herring B, Raktham S, et al. Determination of HIV-1 subtypes in injecting drug users in Bangkok, Thailand, using peptide-binding enzyme immunoassay and heteroduplex mobility assay: evidence of increasing infection with HIV-1 subtype E. AIDS 1995; 9: 843-9.
22. McCutchan FE, Salminen MO, Carr JK, Burke DS. HIV-1 genetic diversity. AIDS 1996; 10 (Suppl 3):S13-S20.
23. Carr JK, Salminen MO, Koch C, et al. Fulllength sequence and mosaic structure of human immunodeficiency virus type 1 isolate from Thailand. J Virol 1996; 70: 5935-43.
24. Gao R, Robertson DL, Morrison SG, et al. The heterosexual human immunodeficiency virus type 1 epidemic in Thailand is caused by an intersubtype (A/E) recombinant of African origin. J Virol 1996; 70: 7013-29.
25. Artenstein AW, VanCott TC, Mascola JR, et al. Dual infection with human immunodeficiency virus type 1 of distinct envelope subtypes in humans. J Infect Dis 1995; 171: 805-10.
26. Munoz A, Sabine CA, Phillips AN. The incubation period of AIDS. AIDS 1997; 11 (Suppl A): S69-76.
27. Wannamethee SG, Sirivichayakul S, Phillips AN, et al. Clinical and immunological features of human immunodeficiency virus infection in patients from Bangkok, Thailand. Int J Epidemiol 1998; 27: 289-95.
28. Sirivichayakul S, Phanuphak P, Hanvanich M, et al. Clinical correlation of the immunological markers of HIV infection in individuals from Thailand. AIDS 1992; 6: 393-7.
29. Kitayaporn D, Tansuphaswadikul S, Lohsomboon P, et al. Survival of AIDS patients in the emerging epidemic in Bangkok, Thailand. J Acquir Immun Def Syndr Hum Retrovirol 1996; 11: 77-82.
30. Yu XF, Wang Z, Beyrer C, et al. Phenotypic and genotypic characteristics of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand. J Virol 1995; 69: 4649-5.
31. Ubolyam S, Ruxrungtham K, Kunanusont C, et al. Natural history of HIV disease in individuals infected with two distinct HIV-1 subtypes in Thailand. The second Asian Pacific Congress of Allergology and Immunology 1995, Taipei, Taiwan, R.O.C. November 18-22, 1995. Abstract no. 199.
32. th Conference on Retroviruses and Opportunistic Infections. Chicago, February 4-8,2001. Abstract no. 207.
33. Anonymous. Time from HIV-1 seroconversion to AIDS and death before widespread use of highlyactive antiretroviral therapy: a collaborative reanalysis. Lancet 2000; 355: 1131-7.
34. Nookhai S, Ruxrungtham K, Phanuphak P, Oelrichs R. Prevalence of CCR2-641, SDF1-3'A and CCR5-Delta32 alleles in healthy Thais. Eur J Immunogenet 2000; 27: 153-7.
35. th ed. New York, McGrawHill, 1998: 1971-856.
36. Carr A, Cooper DA. Primary HIV infection. In: The Medical Mangement of AIDS (Sande M and Volberding P, eds), Philadelphia: WB saunders. 1997; 89-106.
37. Carr A, Cunningham P, Kelleher A, Cooper DA. Diagnosis and treatment of primary HIV infection. J HIV Combination therapy 1997; 2: 49-56.
38. Ruxrungtham K, Muller O, Sirivichayakul S, et al. AIDS at a University Hospital in Bangkok, Thailand. AIDS 1996; 10: 1047-9.
39. Sivayathorn A, Srihra B, Leesanguankul W. Prevalence of skin disease in patients infected with human immunodeficiency virus in Bangkok, Thailand. Ann Acad Med Singapore 1995; 24: 528-33.
40. Anonymous. AIDS situation in Thailand up to May 31, 1998. Division of Epidemiology, Department of Communicable Diseases Control (CDC), Ministry of Public Health.
41. Supparatpinyo K, Khamwan C, Baosoung V, Nelson KE, Sirisanthana T. Disseminated Penicillium marneffei infection in southeast Asia. Lancet 1994; 344: 110-3.
42. Ministry of Public Health, Thailand. National Guidelines for the Clinical Management of HIV Infection in Children and Adults. Sixth ed., 2000, 57-103.
43. Sirisanthana V. Opportunistic infections in HIV-infected children at Chiang Mai University Hospital, Chiang Mai Thailand. J Infect Dis Antimicrob Agents (Thailand) 1995; 12: 59-62.
44. Paliphat T, Thantives S, Keswit W, et al. Situation of multiple drug-resistant tuberculosis in Thailand 1996. Weekly epidemiol surveillance report 1997; 28: 169-79.
45. Thanakitjaru S, Chareonphan P, Kiatboonsri S, et al. Multiple drug-resistant (MDR) tuberculosis in Ramathibodhi hospital: Current status. J Tuberculosis Chest 1996; 17: 209-15.
46. Hongthiamthong P, Riantawan P, Subhannachart P, Fuangtong P. Clinical aspects and treatment outcome in HIV-associated pulmonary tuberculosis: an experience from a Thai referral center. J Med Assoc Thai 1994; 77: 520-5.
47. Nightingale SD, Byrd LT, Southern PM, et al. Incidence of Maycobacterium avium complex bacteremia in HIV-positive patients. J Infect Dis 1992; 165: 1082-5.
48. Sathapatayakul B, Tansupsawasdikul S. Mycobacterium avium complex (MAC) in patients with AIDS. In: Satapatayakul B (ed). HIV/AIDS in Thailand 1996: Adult & Pediatrics. Bangkok: Sawicha Karnpim, 1996: 13-9.
49. Golub B, Folk G, Spink WW. Lung abscess due to Corynebacterium equi. Report of first human infection. Ann Intern Med 1967; 66: 1174-7.
50. Verville TD, Huycke MM, Greenfield RA, et al Rhodococcus equi infection of human: 12 case and review of literature. Medicine 1994; 73: 119-32.
51. Sirisanthana T. Rhodococcosis. In: Satapatayakul B (ed). HIV/AIDS in Thailand 1996: Adult & Pediatrics. Bangkok: Sawicha Karnpim, 1996: 20-3.
52. Srison D, Thisyakorn U, Paupunwatana S, et al. Perinatal HIV infections in Thailand. Southeast Asian J Trop Med Public Health 1995; 26: 659-63.
53. Manatsathit S, Tansupasawasdikul S, Wanachiwanawin D, et al. Causes of chronic diarrhea in patients with AIDS in Thailand: a prospective clinical and microbiological study. J Gastroenterol 1996; 31: 533-7.
54. Moolasart P, Eampokalap B, Ratanasrithong M, et al. Cryptosporidiosis in HIV infected patients in Thailand. Southeast Asian J Trop Med Public Health 1995; 26: 335-8.
55. U.S. Health and Human Service. Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents. Feb 2001. www.hivatis. org.
56. Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults. JAMA. 2000; 2803: 381-91- Centers for Disease Control and Prevention. 1999 USPHA/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV. MMWR 1999; 48 (No. RR-10): 1-66.
57. Carpenter CC, Cooper DA, Fischl MA, et al. Antiretroviral therapy in adults. JAMA. 2000; 2803: 381-91- Centers for Disease Control and Prevention. 1999 USPHA/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV. MMWR 1999; 48 (No. RR-10): 1-66.
58. British HIV Association (BHIVA) guidelines for antiretroviral treatment of HIV seropositive individuals. March 2001 Draft. Available at www.aidsmap.com.
59. 3 or less. N Engl J Med 1997; 337: 725-33.
60. Palella FJ Jr, Delaney KM, Moorman AC, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 338: 853.
61. Anonymous. AVANTI2. Randomized, doubleblind trial to evaluate the efficacy and satety of zidovudine plus lamivudine versus zidovudine plus lamivudine plus indinavir in HIV-infected antiretroviral-naive patients. AIDS 2000; 14: 367-74.
62. Clumeck N. AVANTI 3: A randomized, double blind, comparative trial to evaluate the efficacy, safety and tolerance of AZT/3TC vs AZT/3TC/ nelfinavir in antiretroviral naïve patients. Fifth Conference on Retroviruses and Opportunistic Infections, Chicago, 1998, Abst. 8.
63. Kroon ED, Ungsedhapand C, Ruxrungtham K, et al. A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research Collaboration. AIDS 2000; 14: 1349-56.
64. Ruxrungtham K, Kroon ED, Ungsedhapand C, et al. A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naive, HIV-infected Thai patients. AIDS 2000; 14: 1375-82.
65. Centers for Disease Control and Prevention. 1999 USPHA/IDSA guidelines for the prevention of opportunistic infections in persons infected with HIV. MMWR 1999; 48 (No. RR-10): 1-66.
66. CDC. Revision of the CDC surveillance case definition for acquired immunodeficiency syndromes. MMWR Morb Mortal Wkly Rep 1987; 36 (Suppl IS): 3-14.
67. Thisyakorn U, Khongphatthanayothin M, Sirivichayakul S, et al. The Thai Red Cross zidovudine donation program to prevent vertical transmission of HIV: the effect of the modified ACTG 076 regimen. AIDS 2000; 14: 2921-7.
68. UNAIDS Best Practice Collection. Prevention of Mother-to-Child Transmission of HIV: Thai Red Cross Zidovudine Donation Program. September 2000.
69. Phanuphak P, Grayson ML, Sirivichayakul S, et al. A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia. Aust NZJ Med 2000; 30: 11-20.
70. Phanuphak P, Cooper DA, Lange JM. Clinical trials in Asia. AIDS 1998; 12 (Suppl B): S163-7.
71. Ruxrungtham K, Suwanagool S, Tavel JA, et al. A randomized, controlled 24-week study of intermittent subcutaneous interleukin-2 in HIV-1 infected patients in Thailand. Vanguard Study Group. AIDS 2000; 14: 2509-13.
72. Lallemant M, Jourdain G, Le Coeur S, et al. A trial of shortened zidovudine regimens to prevent mother-to-child transmission of human immunodeficiency virus type 1. Perinatal HIV Prevention Trial (Thailand) Investigators. N Engl J Med 2000; 343: 982-91.
73. Anonymous. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmissio-Thailand, 1996-1998. MMWR Morb Mortal Wkly Rep 1998; 47: 151-4.
74. Phanuphak P, Teeratakulpixarn S, Sarangbin S, et al. International clinical trials of HIV vaccines: I. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand. Asian Pac J Allergy Immunol 1997; 15: 41-8.
75. Thiamchai V. 2000 Annual Report: HIV Vaccine Development and Evaluation in Thailand. AIDS Vaccine Coordinating Unit, AIDS Division, Department of Communicable Diseases Control, Ministry of Public Health, Thailand.
76. Nitayaphan S, Khamboonruang C, Sirisophana N, et al. A phase I/II trial of HIV SF2 gp120/MF59 vaccine in seronegative thais. AFRIMS-RIHES Vaccine Evaluation Group. Armed Forces Research Institute of Medical Sciences and the Research Institute for Health Sciences. Vaccine 2000; 18: 1448-55.